CLEVELAND - A new weight loss drug hits the market Tuesday.
Belviq was approved by the Federal Drug Administration in 2012. The drug's approval was delayed because it has a potential for abuse and needed a controlled substance classification.
Belviq increases the feeling of fullness and lowers cravings in some patients by stimulating receptors in the brain.
The drug is only available with a prescription. Possible side effects include depression, migraines and memory lapses.
Copyright 2013 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
An Akron woman finally accessed the troubled healthcare.gov website Monday only to find she can't afford the insurance they're offering.
The folks in charge of fixes at Healthcare.gov released a progress report on the capacity and performance of the health insurance shopping and enrollment system on Sunday.